A Gilead Sciences scientist analyzes a patient’s antibody levels at the Gilead Laboratory in Foster City, California. David Paul Morris | Bloomberg | Getty Images Gilead Sciences will acquire the biotech company Immunomedics in a 21 billion deal that will expand the availability of Gilead cancer treatments, the companies announced …
Read More »Gilead to buy cancer drug maker Immunomidics for 21 billion
